Literature DB >> 8210943

The morphology, immunohistochemistry, and incidence of hematopoietic neoplasms in mice and rats.

C H Frith1, J M Ward, M Chandra.   

Abstract

Hematopoietic neoplasms in the rodent may be classified into lymphoid or nonlymphoid neoplasms. Lymphoid neoplasms include the following morphologic types: follicular center cell, lymphoblast (lymphocytic), immunoblast, plasma cell, and large granular lymphocyte (LGL). Nonlymphoid hematopoietic neoplasms include histiocytic sarcoma, granulocytic leukemia, erythroid leukemia, and mast cell tumors. Most types of hematopoietic neoplasms, exclusive of LGL lymphoma (leukemia), are more common in mice than in rats. Specific strains of mice have a hematopoietic tumor incidence of more than 50% in aged animals. Some strains of rats (i.e., Fischer-344) may have an incidence of over 50% of LGL lymphoma in aged animals. The tumor type and incidence are characteristic for each rat or mouse strain. Hematopoietic neoplasms have been better characterized immunomorphologically in mice than in rats. The specific cell type and tissue of origin for hematopoietic neoplasms may be important for safety evaluation of chemicals. Specific chemicals may induce specific types of these tumors, which may be the same or different from the spontaneous types. Lymphoid cell neoplasms should not be grouped with nonlymphoid neoplasms in determining the toxicity and carcinogenicity of test substances.

Entities:  

Mesh:

Year:  1993        PMID: 8210943     DOI: 10.1177/019262339302100213

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  26 in total

1.  The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice.

Authors:  X Hao; T N Fredrickson; S K Chattopadhyay; W Han; C-F Qi; Z Wang; J M Ward; J W Hartley; H C Morse
Journal:  Vet Pathol       Date:  2010-05       Impact factor: 2.221

Review 2.  The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms).

Authors:  Robert R Maronpot; Abraham Nyska; Jennifer E Foreman; Yuval Ramot
Journal:  Crit Rev Toxicol       Date:  2016-06-09       Impact factor: 5.635

3.  Neoplastic transformation and angiogenesis in the thymus of transgenic mice expressing SV40 T and t antigen under an L-pyruvate kinase promoter (SV12 mice).

Authors:  Bernadette Nabarra; Christiane Pontoux; Cecile Godard; Mary Osborne-Pellegrin; Sophie Ezine
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

4.  Useful immunohistochemical markers of tumor differentiation.

Authors:  J T Painter; N P Clayton; R A Herbert
Journal:  Toxicol Pathol       Date:  2009-12-22       Impact factor: 1.902

5.  Carcinogenesis studies of benzophenone in rats and mice.

Authors:  M C Rhodes; J R Bucher; J C Peckham; G E Kissling; M R Hejtmancik; R S Chhabra
Journal:  Food Chem Toxicol       Date:  2006-11-15       Impact factor: 6.023

6.  Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP.

Authors:  A L Kung; V I Rebel; R T Bronson; L E Ch'ng; C A Sieff; D M Livingston; T P Yao
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

7.  Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations.

Authors:  Andrii I Rozhok; James DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-21       Impact factor: 11.205

8.  Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins.

Authors:  Amit C Nathwani; Cecilia Rosales; Jenny McIntosh; Ghasem Rastegarlari; Devhrut Nathwani; Deepak Raj; Sushmita Nawathe; Simon N Waddington; Roderick Bronson; Scott Jackson; Robert E Donahue; Katherine A High; Federico Mingozzi; Catherine Y C Ng; Junfang Zhou; Yunyu Spence; M Beth McCarville; Marc Valentine; James Allay; John Coleman; Susan Sleep; John T Gray; Arthur W Nienhuis; Andrew M Davidoff
Journal:  Mol Ther       Date:  2011-01-18       Impact factor: 11.454

9.  The evolution of lifespan and age-dependent cancer risk.

Authors:  Andrii I Rozhok; James DeGregori
Journal:  Trends Cancer       Date:  2016-10

10.  Neonatal intravenous injection of a gammaretroviral vector has a low incidence of tumor induction in mice.

Authors:  Mindy Tittiger; Xiucui Ma; Lingfei Xu; Katherine P Ponder
Journal:  Hum Gene Ther       Date:  2008-11       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.